PPT-CROI 2015: Hot Topics in HIV Primary Care

Brian R Wood MD Assistant Professor of Medicine University of Washington Medical Director NW AETC ECHO March 5 2015 ECHO CROI Reviews 2015 3515 31215 31915 Brian Wood Primary Care. Scott Letendre, M.D.. Professor of . Medicine and Psychiatry. University of California, San Diego. Disclosures. Funds for investigator-initiated research were paid to University of California, San Diego:. Nina Kim, MD . Associate Professor of Medicine. Division of Allergy & Infectious Diseases. University of Washington. No financial conflicts of interest. ION-4. Ledipasvir-Sofosbuvir. for 12 weeks. Weill Cornell Medicine. New York, New York. Investigational . Antiretroviral Drugs. FORMATTED. : . 01-13-17. New York, New York: February 24, 2017 . Learning Objectives. After attending this presentation. Presented by:. Doug Backman. Hot . Topics in Research . Administration. June 5, 2013. Presented by. Doug Backman. Exploring Research Administration…for CONCEPT to COMMERCIALIZATION. INTRODUCTION TO SPARKS2. Selected National HIV Prevention and Care Outcomes. Used to gauge progress towards national HIV prevention and care goals and direct resources most effectively. Monitors steps required from the time a person . Clinical and immunologic pattern of PLHIV lost from HIV care before initiated Antiretroviral treatment within an HIV Program in Tanzania Aisa N Muya, MD, MPH Management and Development for Health ( MDH) New Drugs in Development Are We Ready for Long-Acting ART? Melanie A. Thompson, MD AIDS Research Consortium of Atlanta Follow me on Twitter @ drmt Financial Relationships With Commercial Entities Dr Thompson's institution has received grants for research from Bristol-Myers Squibb, CytoDyn, Inc, Frontier Biotechnologies, Gilead Sciences, Inc, GlaxoSmithKline, p. resented by. NCATEC. March . 18, . 2014. David . Wohl. , MD. Joe . Eron. , MD. Conference Call Line: (. 919) 962-. 2731 - Please mute your phones.. CROI 2014 Update: Implications for the Future of HIV Management. amoe@mednet.ucla.edu. UCLA CARE clinic/NEVHC Van Nuys . 21 June 2014. I do not have any financial arrangements or affiliations with commercial sponsors which have direct interest in the subject matter. Shireesha Dhanireddy. Robert Harrington. March 17, 2014. No financial conflicts of interest. Outline. Treatment Studies. Tenofovir. . alafenamide. (TAF) in a single-tablet regimen in initial HIV-1 infection . CROI Update 2016. FORMATTED: MM/DD/YY. From . H . Masur. , MD, . at Washington, DC: April 15, 2016, IAS-USA. . Oral Abstract. Estimating the Lifetime Risk of HIV Infection in the United States. Kristen Hess et al. San . Francisco Department . of Public Health. Clinical Professor of Medicine and Epidemiology. University of California San Francisco. San Francisco, California. Maximizing the Benefits of . Pre-Exposure Prophylaxis (. September 2015. Jenny Benton. Head of Monitoring, Evaluation and Learning. This presentation shows the results from Teacher Training Colleges and Primary Schools for the academic year 2014 – 2015. All 6 TTCs are present and within each all 40 core-group members were surveyed with the . Alafenamide. in Renal Impairment. A Pozniak. 1. , J Arribas. 2. , . SK Gupta. 3. , . FA Post. 4. , A Avihingsanon. 5. , . G Crofoot. 6. , . K Lichtenstein. 7. , M Ramgopal. 8. , P Chetchotisakd. 9. , MW Fordyce.